Skip to main content
. 2013 Jun 5;105(14):1043–1049. doi: 10.1093/jnci/djt124

Table 1.

Baseline characteristics of women with at least one benign breast biopsy

Characteristic No breast cancer, no. (n = 41459) Breast cancer, no.
(n = 1359)
P*
Pathology from benign biopsy <.001
 Nonproliferative 29138 (70.3%) 792 (58.3%)
 Proliferative disease without atypia 10483 (25.3%) 431 (31.7%)
 Atypical hyperplasia 1838 (4.4%) 136 (10.0%)
Breast density† <.001
 Almost entirely fat 1920 (4.6%) 39 (2.9%)
 Scattered fibroglandular densities 15892 (38.3%) 436 (32.1%)
 Heterogeneously dense 18424 (44.4%) 667 (49.1%)
 Extremely dense 5223 (12.6%) 217 (16.0%)
Age at biopsy, y <.001
 30–39 4928 (11.9%) 58 (4.3%)
 40–49 14987 (36.1%) 413 (30.4%)
 50–59 11340 (27.4%) 382 (28.1%)
 60–69 5942 (14.3%) 291 (21.4%)
 70–79 3361 (8.1%) 169 (12.4%)
 ≥80 901 (2.2%) 46 (3.4%)
Race or ethnicity .008
 White, non-Hispanic 32319 (78.0%) 1098 (80.8%)
 Black, non-Hispanic 2749 (6.6%) 78 (5.7%)
 Asian 571 (1.4%) 19 (1.4%)
 Hispanic 2230 (5.4%) 59 (4.3%)
 Other/mixed 847 (2.0%) 11 (0.8%)
 Unknown/not reported 2743 (6.6%) 94 (6.9%)
Family history of breast cancer in first-degree relative 5879 (16.9%) 272 (24.3%) <.001
Postmenopausal 18134 (52.2%) 780 (66.7%) <.001
Current hormone therapy use 7920 (20.8%) 355 (29.3%) <.001
Nulliparous 3576 (14.3%) 143 (15.3%) .40
Age at first live birth ≥30 y (if parous) 2596 (12.9%) 103 (13.8%) .52
Body mass index, kg/m2 .66
 <18.5 479 (1.9%) 14 (1.6%)
 18.5 to <25 11144 (44.3%) 387 (43.8%)
 25 to <30 7065 (28.1%) 244 (27.6%)
 30 to <35 3826 (15.2%) 150 (17.0%)
 ≥35 2619 (10.4%) 89 (10.1%)

* Two-sided P value using the χ2 test.

† Using the Breast Imaging Reporting and Data System (BI-RADS) density categories: 1 = almost entirely fat (low density); 2 = scattered fibroglandular densities (average density); 3 = heterogeneously dense (high density); 4 = extremely dense (very high density).